Stock 600276 JIANGSU HENGRUI MEDICINE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Hengrui Medicine Co., Ltd.

Equities

600276

CNE0000014W7

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
44.3 CNY +1.37% Intraday chart for Jiangsu Hengrui Medicine Co., Ltd. +4.60% -2.06%
07:16am Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% MT
Apr. 17 Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products:

- anti-tumor drugs (No. 1 Chinese);

- Anesthetic drugs;

- contrast agents: used in medical imaging;

- anti-inflammatory drugs;

- drugs for the treatment of cardiovascular diseases.

Number of employees: 19,611

Sales per Business

CNY in Million2022Weight2023Weight Delta
Anti-tumor
53.5 %
11,313 53.2 % 12,217 53.5 % +7.99%
Analgesia Anesthesia
16.4 %
3,336 15.7 % 3,743 16.4 % +12.21%
Other
16.1 %
3,836 18.0 % 3,674 16.1 % -4.20%
Contrast Agent
12.0 %
2,729 12.8 % 2,742 12.0 % +0.50%
Other Business
1.9 %
62 0.3 % 443 1.9 % +611.05%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
97.2 %
20,434 96.3 % 21,760 97.2 % +6.49%
Abroad
2.8 %
779 3.7 % 617 2.8 % -20.83%

Managers

Managers TitleAgeSince
Hong Bin Dai CEO
 Chief Executive Officer 48 00-06-30
Jian Jun Liu DFI
 Director of Finance/CFO 47 21-11-18
Yu Xu CMP
 Compliance Officer 32 21-05-31
Ning Jun Jiang BRD
 Director/Board Member 63 23-02-01
Guo Qiang Xiong BRD
 Director/Board Member 49 04-12-31
Lian Shan Zhang BRD
 Director/Board Member 63 10-08-05
Jie Ping Sun BRD
 Director/Board Member 54 97-12-31
Fei Tian IRC
 Investor Relations Contact - -
Xiao Han Liu SEC
 Corporate Secretary 39 11-07-31
Su Mei Jiang PRN
 Corporate Officer/Principal 61 99-12-31

Members of the board

Members of the board TitleAgeSince
Jie Ping Sun BRD
 Director/Board Member 54 97-12-31
Hong Bin Dai CEO
 Chief Executive Officer 48 00-06-30
Piao Yang Sun CHM
 Chairman 65 03-02-28
Su Mei Jiang PRN
 Corporate Officer/Principal 61 99-12-31
Kai Hong Yuan CHM
 Chairman - 86-12-31
Lian Shan Zhang BRD
 Director/Board Member 63 10-08-05
Guo Qiang Xiong BRD
 Director/Board Member 49 04-12-31
Ning Jun Jiang BRD
 Director/Board Member 63 23-02-01
Cong Zhao Guo BRD
 Director/Board Member 52 20-01-15
Yu Xu CMP
 Compliance Officer 32 21-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,379,002,274 3,258,210,645 ( 51.08 %) 24,048,577 ( 0.3770 %) 51.08 %

Shareholders

NameEquities%Valuation
Piao Yang Sun
24.16 %
1,538,184,187 24.16 % 9 784 M ¥
Tibet Dazi Dayuan Business Management Co. Ltd.
14.96 %
952,752,304 14.96 % 6 060 M ¥
China State-Owned Assets Supervision & Admn Commission
4.120 %
262,344,248 4.120 % 1 669 M ¥
Qingdao Bosentai Investment Partnership LP
2.870 %
182,756,856 2.870 % 1 162 M ¥
Zhong Ou Asset Management Co., Ltd
1.884 %
119,982,579 1.884 % 763 M ¥
Lianyungang Finance Holding Group Co. Ltd.
1.847 %
117,609,880 1.847 % 748 M ¥
China Securities Finance Corp. Ltd.
1.498 %
95,399,822 1.498 % 607 M ¥
China Asset Management Co., Ltd.
1.002 %
63,772,597 1.002 % 406 M ¥
China Investment Corp. (Investment Management)
0.9126 %
58,111,212 0.9126 % 370 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.8705 %
55,429,959 0.8705 % 353 M ¥

Holdings

NameEquities%Valuation
JIANGSU HENGRUI MEDICINE CO., LTD.
0.35%
 22,254,027 0.35% 141,546,071 $

Company contact information

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

7 Kunlunshan Road Economic & Technological Devt Zone

222000, Lianyungang

+

http://www.hengrui.com
address Jiangsu Hengrui Medicine Co., Ltd.(600276)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Jiangsu Hengrui Medicine Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
44.3 CNY
Average target price
57.6 CNY
Spread / Average Target
+30.02%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU HENGRUI MEDICINE CO., LTD. Stock Jiangsu Hengrui Medicine Co., Ltd.
-2.06% 38.88B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 233B
NOVARTIS AG Stock Novartis AG
+6.04% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 193B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 143B
AMGEN INC. Stock Amgen Inc.
-6.47% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600276 Stock
  4. Company Jiangsu Hengrui Medicine Co., Ltd.